Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction.

Human gene therapy

Volumn 23, Issue 10, 2012, Pages 1031-1042

  Messina, Emily L ^a   Nienaber, Jeffrey ^b   Daneshmand, Mani ^b   Villamizar, Nestor ^b   Samulski, Jude ^b   Milano, Carmelo ^b   Bowles, Dawn E ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLYCOSAMINOGLYCAN; HEPARIN; LUCIFERASE; SIGNAL PEPTIDE;

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; CLASSIFICATION; DRUG EFFECT; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; GENOTYPE; HUMAN; IN VITRO STUDY; METABOLISM; METHODOLOGY; MOUSE; SAPHENOUS VEIN; SEROTYPING; SOLUBILITY; SWINE; TISSUE CULTURE TECHNIQUE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DEPENDOVIRUS; GENETIC THERAPY; GENETIC VECTORS; GENOTYPE; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MICE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SAPHENOUS VEIN; SEROTYPING; SOLUBILITY; SUS SCROFA; TISSUE CULTURE TECHNIQUES; TRANSDUCTION, GENETIC;

EID: 84880877500     PISSN: None     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.066     Document Type: Article

References (0)